Description
Tivomax-Darnitsa (arginine) Solution for Infusions
Composition: Each 100 ml. vial contains 42 mg/ml. of arginine.
Description:
Tivomax-Darnitsa is a Solution for Infusion containing arginine. Arginine is an amino acid that plays a crucial role in various physiological processes in the body. This solution is formulated to be administered intravenously to help support specific health conditions that may benefit from arginine supplementation.
Indications:
Tivomax-Darnitsa is indicated for use in the following conditions:
- Supporting cardiovascular health
- Enhancing wound healing
- Improving immune function
- Assisting in the treatment of certain metabolic disorders
Mechanism of Action:
Arginine, the active ingredient in Tivomax-Darnitsa, is a precursor to nitric oxide, a molecule that plays a key role in vasodilation and blood flow regulation. By increasing nitric oxide production, arginine may help improve blood circulation and support cardiovascular health. Additionally, arginine is involved in protein synthesis, immune function, and wound healing processes.
Administration and Dosage:
Tivomax-Darnitsa is intended for intravenous administration under the supervision of a healthcare professional. The dosage and infusion rate will vary depending on the specific indication being treated and the patient’s individual needs. It is important to follow the healthcare provider’s instructions regarding the proper administration of this solution.
Contraindications:
Tivomax-Darnitsa is contraindicated in individuals with a known hypersensitivity to arginine or any of the other ingredients in the solution. It should not be used in patients with severe renal impairment or in those with certain metabolic disorders that may be worsened by arginine supplementation.
Adverse Effects:
While Tivomax-Darnitsa is generally well-tolerated, some patients may experience minor side effects such as nausea, vomiting, or allergic reactions. In rare cases, high doses of arginine may cause gastrointestinal discomfort, changes in blood pressure, or electrolyte imbalances. It is important to report any adverse effects to the healthcare provider promptly.
Precautions:
Prior to administering Tivomax-Darnitsa, healthcare providers should assess the patient’s medical history, current medications, and overall health status to determine the appropriateness of using this solution. Close monitoring of vital signs and laboratory parameters may be necessary during infusion to ensure the patient’s safety.
Storage:
Tivomax-Darnitsa should be stored in a cool, dry place away from direct sunlight and heat sources. The vials should be kept in their original packaging until ready for use to protect them from contamination. Do not freeze the solution, and discard any unused portion according to local regulations.
Conclusion:
In summary, Tivomax-Darnitsa is a Solution for Infusion containing arginine, an amino acid with various physiological functions. This medication is used to support cardiovascular health, wound healing, immune function, and metabolic processes in patients who may benefit from arginine supplementation. It is important to follow the healthcare provider’s instructions for administration and monitoring while using this solution. If you have any questions or concerns about Tivomax-Darnitsa, be sure to discuss them with your healthcare provider for personalized guidance.
